LGG Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with LGG
C
- carbetapentane / chlorpheniramine / ephedrine / phenylephrine
- Carbomix (charcoal)
- Carbosorb X (charcoal)
- carteolol
- carteolol ophthalmic
- Cartrol (carteolol)
- carvedilol
- Char-Flo Aqueous Base (charcoal)
- Char-Flo with Sorbitol (charcoal / sorbitol)
- Charcoaid (charcoal)
- Charcoaid 2000 (charcoal)
- Charcoaid-G (charcoal)
- charcoal
- Charcoal Plus DS (charcoal)
- charcoal / simethicone
- charcoal / sorbitol
- Charcocaps (charcoal)
- Charcodote (charcoal)
- Charcotabs (charcoal)
- Charcotrace (charcoal)
- Chem Mart Nasal Decongestant Capsule (charcoal)
- chlordiazepoxide
- chlordiazepoxide / clidinium
- chlordiazepoxide / methscopolamine
- Chlordinium (chlordiazepoxide / clidinium)
- chlorpheniramine / ephedrine / guaifenesin
- cilastatin / imipenem
- cilastatin / imipenem / relebactam
- cisatracurium
- Clindex (chlordiazepoxide / clidinium)
- clobazam
- clonazepam
- clorazepate
- colchicine / probenecid
- colesevelam
- Columvi (glofitamab)
- Combigan (brimonidine / timolol ophthalmic)
- Combivent (albuterol / ipratropium)
- Combivent Respimat (albuterol / ipratropium)
- Coreg (carvedilol)
- Coreg CR (carvedilol)
- Corgard (nadolol)
- Corphedra (ephedrine)
- Corzide (bendroflumethiazide / nadolol)
- Corzide 40 / 5 (bendroflumethiazide / nadolol)
- Corzide 80 / 5 (bendroflumethiazide / nadolol)
- Cosopt (dorzolamide / timolol ophthalmic)
- Cosopt PF (dorzolamide / timolol ophthalmic)
More about LGG (dyphylline / guaifenesin)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiasthmatic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.